03:26 AM EDT, 09/05/2025 (MT Newswires) -- Eugene Schneider, Executive Vice President, Chief Clinical Development Officer, on September 03, 2025, sold 19,658 shares in Ionis Pharmaceuticals ( IONS ) for $1,195,421. Following the Form 4 filing with the SEC, Schneider has control over a total of 51,507 common shares of the company, with 51,507 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/874015/000087401525000211/xslF345X05/edgardoc.xml